ConductScience.org, home

Gene · 407014

NIH grants1,360

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleMIR25 papersNewest fiscal year
T32AI007392Interdisciplinary Research Training Program in AIDS22025
T32ES007026Training in Environmental Toxicology22025
UL1TR001863Yale Clinical and Translational Science Award22025
ZIAAG000511Post-transcriptional control of Proliferation, Stress Response & Carcinogenesis22025
ZIAAG000519The Underlying Biology of Health Disparities22025
ZIABC010309Nuclear Architecture and Disease22025
ZIABC010499Maryland Prostate Cancer Case-Control Study22025
ZIACL002119Develop novel assays for assessing cellular and gene therapies22025
ZICAG000616Analysis of complex biological systems by high-throughput genomic technologies22025
F30EY033642microRNA-204 and microRNA-211 regulation of RPE phagocytosis12025
I01BX000163Leveraging mitochondrial function to combat radiation therapy-induced microvascular disease12025
I01BX000332Posttranscriptional Control of Gut Mucosal Defense and Homeostasis12025
I01BX001790Bladder Dysfunction and Dysregulation of Neurotransmission12025
I01BX001963Molecular Regulators of Mitochondria in Diabetic Cardiomyopathy12025
IK6BX004601BLR&D Research Career Scientist Award12025
IK6BX005229BLR&D Merit Review Research Career Scientist Award Application12025
K12HD001399Child Health Research Career Development Award (CHRCDA) Program at Children's National12025
P01AG036675Kynurenine accumulation drives loss of muscle and bone function with aging12025
P01AG036695Molecular Regulation of Stem Cell Aging12025
P01CA013106Targeting Transcription and Splicing in Cancer12025

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/407014/grants?page=3